148 related articles for article (PubMed ID: 6415371)
21. Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs.
Matsuzaki T; Yokokura T; Azuma I
Cancer Immunol Immunother; 1985; 20(1):18-22. PubMed ID: 3933816
[TBL] [Abstract][Full Text] [Related]
22. [Antitumor activity of Lactobacillus casei YIT 9018 (LC 9018)--effect of administration route].
Yokokura T; Kato I; Matsuzaki T; Mutai M; Satoh H
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2427-33. PubMed ID: 6437346
[TBL] [Abstract][Full Text] [Related]
23. Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice.
Mike A; Nagaoka N; Tagami Y; Miyashita M; Shimada S; Uchida K; Nanno M; Ohwaki M
Clin Exp Immunol; 1999 Aug; 117(2):368-75. PubMed ID: 10444272
[TBL] [Abstract][Full Text] [Related]
24. Host-mediated antiviral activity of Lactobacillus casei against cytomegalovirus infection in mice.
Ohashi T; Yoshida A; Minamishima Y
Biotherapy; 1988; 1(1):27-39. PubMed ID: 2484431
[TBL] [Abstract][Full Text] [Related]
25. Oral immunization with recombinant Lactobacillus casei expressing flaB confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
Kong YD; Kang YH; Tian JX; Zhang DX; Zhang L; Tao LT; Wu TL; Li Y; Wang GQ; Shan XF
Fish Shellfish Immunol; 2019 Apr; 87():627-637. PubMed ID: 30708057
[TBL] [Abstract][Full Text] [Related]
26. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens.
Kato I; Yokokura T; Mutai M
Microbiol Immunol; 1984; 28(2):209-17. PubMed ID: 6427563
[TBL] [Abstract][Full Text] [Related]
27. [Induction of interferon by Lactobacillus].
Goto T; Yokota Y; Matsumoto K; Nakai M; Yamagata H
Kansenshogaku Zasshi; 1988 Dec; 62(12):1105-10. PubMed ID: 2466096
[No Abstract] [Full Text] [Related]
28. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice.
Yasutake N; Ohwaki M; Mutai M; Koide Y; Yoshida T
Cancer Immunol Immunother; 1985; 20(2):109-16. PubMed ID: 3930065
[TBL] [Abstract][Full Text] [Related]
30. Construction and immune efficacy of recombinant Lactobacillus casei strains expressing Malt from Aeromonas veronii.
Ju AQ; Yang SB; Zhang HP; Ma X; Zhang DX; Kang YH; Shi QM; Wu TL; Wang GQ; Qian AD; Shan XF; Luan WM
Microb Pathog; 2020 Apr; 141():103918. PubMed ID: 31935441
[TBL] [Abstract][Full Text] [Related]
31. Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5.
Ishida-Fujii K; Sato R; Goto S; Yang XP; Kuboki H; Hirano S; Sato M
Biosci Biotechnol Biochem; 2007 Apr; 71(4):866-73. PubMed ID: 17420603
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of lipoteichoic acid from Lactobacillus casei and Lactobacillus fermentum against Pseudomonas aeruginosa in mice.
Setoyama T; Nomoto K; Yokokura T; Mutai M
J Gen Microbiol; 1985 Sep; 131(9):2501-3. PubMed ID: 3934337
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of macrophages by immunobiotic Lactobacillus strains: influence beyond the intestinal tract.
Marranzino G; Villena J; Salva S; Alvarez S
Microbiol Immunol; 2012 Nov; 56(11):771-81. PubMed ID: 22846065
[TBL] [Abstract][Full Text] [Related]
34. Effects of single moxibustion on phagocytic activity in mice.
Okazaki M; Furuya E; Kasahara T; Sakamoto K
Am J Chin Med; 1983; 11(1-4):112-22. PubMed ID: 6660199
[TBL] [Abstract][Full Text] [Related]
35. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms.
Shida K; Kiyoshima-Shibata J; Kaji R; Nagaoka M; Nanno M
Immunology; 2009 Sep; 128(1 Suppl):e858-69. PubMed ID: 19740347
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of host resistance to microbial infections in mice fed a high fat diet by Lactobacillus casei cells.
Watanabe T; Hotta C
Hiroshima J Med Sci; 1996 Jun; 45(2):63-8. PubMed ID: 8810133
[TBL] [Abstract][Full Text] [Related]
37. [Phagocytic activity of leaves of Epimedium species on mouse reticuloendotherial system].
Iinuma M; Tanaka T; Sakakibara N; Mizuno M; Matsuda H; Shiomoto H; Kubo M
Yakugaku Zasshi; 1990 Mar; 110(3):179-85. PubMed ID: 2374090
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2).
Asano M; Karasawa E; Takayama T
J Urol; 1986 Sep; 136(3):719-21. PubMed ID: 3090281
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant Lactobacillus casei on growth performance, immune response and disease resistance in crucian carp, Carassius auratus.
Kong Y; Li M; Tian J; Zhao L; Kang Y; Zhang L; Wang G; Shan X
Fish Shellfish Immunol; 2020 Apr; 99():73-85. PubMed ID: 32032762
[TBL] [Abstract][Full Text] [Related]
40. [Enhancement of the phagocytic activity of cells of the mononuclear phagocytosing system by the peroral administration of lactobacilli].
Zaĭtseva LG; Gorskaia EM; Lentsner AA; Shustrova NM
Antibiot Med Biotekhnol; 1986 Sep; 31(9):691-4. PubMed ID: 3777898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
